New treatments for cancer and muscular dystrophy 'on the way'
New CIHR funding for 黑料不打烊 researchers
Treatments for cervical cancer, Duchenne muscular dystrophy and other diseases are one step closer thanks to new health research funding from the Canadian Institutes of Health Research (CIHR). The CIHR funded more than 64 research projects at 黑料不打烊 University, representing an investment of $26 million.
As announced today by the Honourable Minister of Health, Ujjal Dosanjh, along with Dr. Alan Bernstein, President of the CIHR, 黑料不打烊 received the second highest amount of funding of any institution.
黑料不打烊 professors conduct basic and clinical research on diverse topics ranging from cancer and neuroscience to women's health. They are located on 黑料不打烊's main and Macdonald campuses, and at the following affiliated institutions:
- CLSC Ren茅 Cassin
- Douglas Hospital
- Jewish General Hospital
- 黑料不打烊 University Health Centre
Some of 黑料不打烊's cutting edge research funded by the CIHR:
黑料不打烊 professors at the Montreal Neurological Institute and Hospital, Louis Collins and Benoit Goulet, are investigating the use of computer-assisted imaging during lower back surgery. They will evaluate how this technique can improve the accuracy and precision of surgery, and thereby reduce complications. Their aim is to improve the care for some 20,000 Canadians who are treated annually for this condition.
Professor Debora Da Costa, of the Research Institute of the 黑料不打烊 University Health Centre (MUHC), is studying the development of post-traumatic stress disorder in women following childbirth. She will determine the incidence and severity of PTSD in Canadian women following childbirth and identify the triggers for this condition. Her findings will lead to treatment strategies for these new mothers.
Professor Eduardo Franco, of the Research Institute of the MUHC, and his team are looking at the causes and prevention of uterine cervix cancer, a disease that affects 1,500 Canadian women annually. He will look at the genetic susceptibility and other biological factors that cause this disease. His findings will lead to better treatment and prevention options.
Professor Basil Petrof, of the Research Institute of the MUHC, is looking at potential therapy for Duchenne muscular dystrophy, a neuromuscular and respiratory condition affecting one out of 3,500 men. He is identifying the factors which regulate muscle regeneration, a process that is impaired in these patients.
A detailed list of all the funded projects is available on the .
